Entry Point Capital, LLC Care Dx, Inc. Transaction History
Entry Point Capital, LLC
- $68.4 Billion
- Q2 2024
A detailed history of Entry Point Capital, LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 3,527 shares of CDNA stock, worth $81,050. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,527Holding current value
$81,050% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding CDNA
# of Institutions
161Shares Held
53.5MCall Options Held
60.8KPut Options Held
34.9K-
Black Rock Inc. New York, NY5.29MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.38MShares$101 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.91MShares$89.9 Million1.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$68.7 Million0.89% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.2.58MShares$59.2 Million0.03% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.23B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...